(BCHMF)

$74.45 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing...

Industry: Chemicals
Sector: Basic Materials
Phone: 41 58 595 2021
Fax: 41 58 595 2043
Address:
Hauptstrasse 144, Bubendorf, Switzerland
Fingerlickengood
Fingerlickengood Jul. 25 at 4:57 PM
$CDXS $BCHMF $NVO $ALNY This is starting to add up.... https://www.bachem.com/articles/news/bachem-novo-nordisk-redesign-spps-for-green-chemistry/
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 25 at 1:42 PM
$CDXS $BCHMF We are definitely in good company! https://www.koreabiomed.com/news/articleView.html?idxno=28359
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 24 at 1:06 PM
$CDXS $BCHMF "The Bachem Group (SIX: BANB) achieved sales of CHF 313.0 million in the first half of 2025 (+30.2% compared to the prior-year period: CHF 240.3 million). In local currencies (LC), sales increased by 34.1%." Great partner to have! https://www.newsfilecorp.com/release/259916/Bachem-Shows-Strong-Growth-in-the-First-Half-of-2025
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 24 at 1:04 PM
$CDXS $BCHMF "a scale-up of manufacturing needs is expected in the medium term, which again favors suppliers who can offer innovative solutions for more efficient production." Who does that sound like?! https://www.bachem.com/about-bachem/investors-and-media/reports-and-presentations/
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 23 at 2:29 PM
$CDXS $BCHMF This might be worth tuning into tomorrow... https://us06web.zoom.us/webinar/register/WN_OXMTQe3bRjKmtABLZ72Zyg#/registration
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 9 at 4:13 PM
$CDXS $BCHMF $LLY Im thinking the GMP inspection of the ECO Innovation Lab happened as they said last month by the FDA and are awaiting the final response from the FDA to move forward IOT begin commercial operations. Fingers crossed! https://www.fda.gov/drugs/guidance-compliance-regulatory-information/pharmaceutical-inspections-and-compliance
1 · Reply
Fingerlickengood
Fingerlickengood Jul. 6 at 8:48 PM
$CDXS $BCHMF Was the FDA meeting in June regarding GLP regulations and approval of the ECO Synthesis Innovation Lab to scale production of siRNA material?
2 · Reply
Fingerlickengood
Fingerlickengood Jul. 3 at 3:23 PM
$CDXS $NVS $BCHMF Confirmed from a company update published and available on their (ST Pharm) website from 2021 when the COVID vaccine was the highlight of their work.....this is SIGNIFICANT imho! https://www.stpharm.co.kr/en/ir/ir-materials/analyst-report-developing-a-covid-19-mrna-vaccine
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 24 at 9:58 PM
$CDXS $BCHMF
2 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 7:55 PM
$CDXS $BCHMF $NVS $ALNY https://www.pharmacytimes.com/view/nla-2025-inclisiran-with-standard-care-provides-rapid-sustained-lowering-of-ldl-c-in-patients-with-recent-acute-coronary-syndrome
1 · Reply
Latest News on BCHMF
No data available.
Fingerlickengood
Fingerlickengood Jul. 25 at 4:57 PM
$CDXS $BCHMF $NVO $ALNY This is starting to add up.... https://www.bachem.com/articles/news/bachem-novo-nordisk-redesign-spps-for-green-chemistry/
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 25 at 1:42 PM
$CDXS $BCHMF We are definitely in good company! https://www.koreabiomed.com/news/articleView.html?idxno=28359
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 24 at 1:06 PM
$CDXS $BCHMF "The Bachem Group (SIX: BANB) achieved sales of CHF 313.0 million in the first half of 2025 (+30.2% compared to the prior-year period: CHF 240.3 million). In local currencies (LC), sales increased by 34.1%." Great partner to have! https://www.newsfilecorp.com/release/259916/Bachem-Shows-Strong-Growth-in-the-First-Half-of-2025
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 24 at 1:04 PM
$CDXS $BCHMF "a scale-up of manufacturing needs is expected in the medium term, which again favors suppliers who can offer innovative solutions for more efficient production." Who does that sound like?! https://www.bachem.com/about-bachem/investors-and-media/reports-and-presentations/
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 23 at 2:29 PM
$CDXS $BCHMF This might be worth tuning into tomorrow... https://us06web.zoom.us/webinar/register/WN_OXMTQe3bRjKmtABLZ72Zyg#/registration
0 · Reply
Fingerlickengood
Fingerlickengood Jul. 9 at 4:13 PM
$CDXS $BCHMF $LLY Im thinking the GMP inspection of the ECO Innovation Lab happened as they said last month by the FDA and are awaiting the final response from the FDA to move forward IOT begin commercial operations. Fingers crossed! https://www.fda.gov/drugs/guidance-compliance-regulatory-information/pharmaceutical-inspections-and-compliance
1 · Reply
Fingerlickengood
Fingerlickengood Jul. 6 at 8:48 PM
$CDXS $BCHMF Was the FDA meeting in June regarding GLP regulations and approval of the ECO Synthesis Innovation Lab to scale production of siRNA material?
2 · Reply
Fingerlickengood
Fingerlickengood Jul. 3 at 3:23 PM
$CDXS $NVS $BCHMF Confirmed from a company update published and available on their (ST Pharm) website from 2021 when the COVID vaccine was the highlight of their work.....this is SIGNIFICANT imho! https://www.stpharm.co.kr/en/ir/ir-materials/analyst-report-developing-a-covid-19-mrna-vaccine
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 24 at 9:58 PM
$CDXS $BCHMF
2 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 7:55 PM
$CDXS $BCHMF $NVS $ALNY https://www.pharmacytimes.com/view/nla-2025-inclisiran-with-standard-care-provides-rapid-sustained-lowering-of-ldl-c-in-patients-with-recent-acute-coronary-syndrome
1 · Reply
valueforme
valueforme Jun. 5 at 5:40 PM
$BCHMF RIP Peter Grogg. I did not think this can happen so quickly after this post. $CDXS
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 3 at 10:33 PM
$CDXS Sad news....he was probably the only thing standing in the way of the company being sold to a larger pharma company such as $LLY...this could change the dynamics here very quickly if $BCHMF is sold. https://www.newsfilecorp.com/release/254344/Bachem-Mourns-the-Loss-of-Company-Founder-Dr.-H.C.-Peter-Grogg
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:38 PM
$CDXS $BCHMF $NVS $ALNY FYI...."Inclisiran is being developed by The Medicines Company, a subsidiary of Novartis, which licensed the rights to inclisiran from Alnylam Pharmaceuticals."
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:35 PM
$CDXS $BCHMF Let's see where this goes, looks like a near match to me! https://www.biospace.com/press-releases/codexis-landmark-presentations-at-tides-usa-highlight-reproducibility-and-process-simplification-of-the-eco-synthesis-platform-for-manufacturing-sirna
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:29 PM
$CDXS $BCHMF Note the fine print.... https://www.pharmamanufacturing.com/industry-news/news/55292073/bachem-expands-multisite-production-capacities-to-meet-demand-for-peptides-oligonucleotides
0 · Reply
Fingerlickengood
Fingerlickengood May. 20 at 2:18 PM
$CDXS $BCHMF @valueforme "Early access customer testing is on track to initiate in 2024 ahead of an anticipated full commercial launch in 2026." https://www.codexis.com/investors/news-events/press-releases/detail/376/codexis-announces-achievement-of-gram-scale-synthesis-with-its-eco-synthesis-platform
1 · Reply
Fingerlickengood
Fingerlickengood May. 18 at 3:58 PM
$CDXS $BCHMF https://www.hugrik.com/events/551e93da-0e7f-4321-a5ee-e2f174fac124
0 · Reply
Fingerlickengood
Fingerlickengood May. 8 at 8:33 PM
$CDXS $BCHMF $LLY https://cen.acs.org/business/outsourcing/Bachem-Lilly-partner-oligonucleotide-drugs/100/i15
1 · Reply
Fingerlickengood
Fingerlickengood May. 8 at 4:16 PM
$CDXS Food for thought. $BCHMF https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176013539
1 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 11:22 PM
$CDXS $BCHMF
0 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 9:45 PM
$CDXS $BCHMF This is GREAT for both companies! https://informaconnect.com/tides/agenda/2/
0 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 9:30 PM
$CDXS 'commercial contract' ....my guess is $BCHMF https://www.globenewswire.com/news-release/2025/03/24/3047710/24825/en/Codexis-Announces-First-Revenue-Generating-Contract-for-ECO-Synthesis-Manufacturing-Services.html
0 · Reply